Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

DreamHug Medical vs MEDVidi

DreamHug Medical
Graded #386

Lower grade

vs+0.10000000000000142
MEDVidi
Graded #384

Higher grade

The verdict

MEDVidi takes it — 58/100 to 57.9/100, but only just.

MEDVidi grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. MEDVidi is a US telehealth platform whose licensed providers evaluate patients and prescribe GLP-1 weight-management medications, including brand-name Zepbound (tirzepatide) and Wegovy (semaglutide), plus… DreamHug Medical is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueDreamHug Medical +12
57
45
Dose & formulationDreamHug Medical +11
64
53
Clinical oversightMEDVidi +17
60
77
Labs & monitoringMEDVidi +12
50
62
FulfillmentDreamHug Medical +8
67
59
Contract termsMEDVidi +14
41
55
DreamHug Medical · left barMEDVidi · right bar

The numbers

MetricDreamHug MedicalMEDVidi
WeighScore57.9/10058/100
GradeCC
Scorecard rank#386#384
Semaglutide$188/mo (starting dose, compounded)Not disclosed
Tirzepatide$238/mo (starting dose, compounded)Not disclosed
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
DreamHug Medical

Graded #386 · C

Strengths

  • Florida business address disclosed publicly (Pompano Beach, FL) — more transparency than many DTC competitors
  • 100% money-back guarantee if you're not approved
  • Telehealth-only with claimed all-50-state coverage via an 11,000-doctor network
  • LegitScript logo displayed

Where it loses points

  • Tirzepatide not mentioned — semaglutide-only, narrower scope than competitors
  • Pricing not disclosed — fully gated behind sign-up
  • LegitScript ID number not shown (only the logo)
  • Pharmacy partner not disclosed
  • Named medical director not disclosed
MEDVidi

Graded #384 · C

Strengths

  • Licensed providers can prescribe brand-name Zepbound and Wegovy
  • Transparent flat consultation fees (195 dollar initial, 159 dollar follow-up)
  • Prescriptions sent to the patient's pharmacy of choice, so insurance can be used

Where it loses points

  • Consult-fee model: medication is not included and its cost is separate
  • No medication pricing is published
  • State list is shown as a map rather than enumerated

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard